Predicting motifs and secondary structure of steroid aptamers using APTANI

Aptamers are synthetic oligonucleotides that fold into flexible structures and bind to a variety of targets. Aptamers are selected using a biochemistry method called Systematic Evolution of Ligands by Exponential enrichment (SELEX), which can identify specific aptamers capable to bind to target from the pool of billions of random sequences. However, this iterative SELEX process is time consuming and requires specialized lab equipment. APTANI is an existing computational tool that can process the billions of random sequences generated from SELEX and generate secondary structure of the selected aptamer sequence. This can significantly reduce the complexity of SELEX and increase accuracy and throughput in lesser time and resources. Here, APTANI is used to analyze existing steroid aptamers (17ß-estradiol, deoxycortisol, estradiol, testosterone) and to identify sequence motifs/patterns and predict their secondary structure. Graphical Abstract Systematic Evolution of Ligands by Exponential enrichment: SELEX begins with an initial library of random sequences in the scale of 10e20 molecules. The library contains a variable region that is flanked by two fixed sequences. The oligonucleotide library is exposed to a desired target. A washing step will remove oligonucleotides that are weakly or unbound to the target. The remaining oligonucleotide-target complex will be separated with an elution step to recover the oligonucleotide sequence and amplified using PCR to regenerate a new pool for the next cycle. The goal of each new cycle is to enrich the high affinity sequences by modifying the binding conditions. The result is high affinity sequences for the target.

[1]  A. Bird,et al.  High-throughput sequencing SELEX for the determination of DNA-binding protein specificities in vitro , 2022, STAR Protocols.

[2]  Shan Liu,et al.  Marine Toxins Detection by Biosensors Based on Aptamers , 2019, Toxins.

[3]  M. El-Shahawi,et al.  One-Pot SELEX: Identification of Specific Aptamers against Diverse Steroid Targets in One Selection , 2019, ACS omega.

[4]  M. Zourob,et al.  Electrochemical SELEX Technique for the Selection of DNA Aptamers against the Small Molecule 11-Deoxycortisol. , 2019, ACS applied bio materials.

[5]  E. Fattal,et al.  Aptamers in Therapeutics and Drug Delivery. , 2018, Advanced drug delivery reviews.

[6]  Quan Yuan,et al.  Simultaneous Visualization and Quantitation of Multiple Steroid Hormones Based on Signal-Amplified Biosensing with Duplex Molecular Recognition. , 2017, Chemistry.

[7]  P. Ballester,et al.  Selection and characterization of DNA aptamers against the steroid testosterone , 2017, Microchimica Acta.

[8]  J. Rossi,et al.  Aptamers as targeted therapeutics: current potential and challenges , 2016, Nature Reviews Drug Discovery.

[9]  Lei Zheng,et al.  Aptamer-Based Technologies in Foodborne Pathogen Detection , 2016, Front. Microbiol..

[10]  Masaaki Kai,et al.  DNA Aptamers in the Diagnosis and Treatment of Human Diseases , 2015, Molecules.

[11]  Silvio Bicciato,et al.  APTANI: a computational tool to select aptamers through sequence-structure motif analysis of HT-SELEX data , 2015, Bioinform..

[12]  L. Michiels,et al.  Aptamers targeting different functional groups of 17β-estradiol , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  M. Zourob,et al.  Aptamer-based label-free impedimetric biosensor for detection of progesterone. , 2015, Analytical chemistry.

[14]  Vivien Marx,et al.  Finding the right antibody for the job , 2013, Nature Methods.

[15]  Weihong Tan,et al.  Aptamers from cell-based selection for bioanalytical applications. , 2013, Chemical reviews.

[16]  Teresa M. Przytycka,et al.  Identification of sequence-structure RNA binding motifs for SELEX-derived aptamers , 2012, Bioinform..

[17]  Yoshikazu Nakamura,et al.  RNA plasticity and selectivity applicable to therapeutics and novel biosensor development , 2012, Genes to cells : devoted to molecular & cellular mechanisms.

[18]  Jay D Keasling,et al.  Model-Driven Engineering of RNA Devices to Quantitatively Program Gene Expression , 2011, Science.

[19]  Anthony D. Keefe,et al.  Aptamers as therapeutics , 2010, Nature Reviews Drug Discovery.

[20]  Peter M. Rice,et al.  The Sanger FASTQ file format for sequences with quality scores, and the Solexa/Illumina FASTQ variants , 2009, Nucleic acids research.

[21]  Chunhai Fan,et al.  Aptamer-based biosensors , 2008 .

[22]  George Quick,et al.  Antidote-mediated control of an anticoagulant aptamer in vivo , 2004, Nature Biotechnology.

[23]  B. Sullenger,et al.  Aptamers: an emerging class of therapeutics. , 2005, Annual review of medicine.